We are pleased to announce that PVpharm will be participating in the World Drug Safety Congress Europe 2025, taking place on October 7–8 in Amsterdam, Netherlands.
About the Congress
This premier event will convene over 1,500 global experts to address the most pressing challenges in drug safety and explore the transformative potential of technologies such as Artificial Intelligence, and digital innovation. The congress will feature key topics including risk management, signal detection, quality assurance, medical devices, patient centricity, and outsourcing.
PVpharm’s Contribution
At PVpharm, we are proud to be part of this dynamic event. Since our founding in 2016, we have built a reputation for delivering tailored solutions to complex regulatory challenges. With a focus on quality, innovation, and partnership, PVpharm supports organizations worldwide in achieving compliance and enhancing patient safety.
During the congress, PVpharm will be present at Stand 48, where its team of expert consultants will engage with industry leaders, regulatory authorities, and partners to discuss best practices and innovative approaches in pharmacovigilance. The company’s participation underscores its commitment to excellence, collaboration, and continuous improvement in drug safety.
Let’s connect!
We warmly invite all attendees to visit us at Stand 48 to learn more about our work, share ideas, and explore opportunities for collaboration. Whether you’re seeking expert support in service for pharmaceutical industry or simply want to connect with our team, we look forward to meeting you in Amsterdam.
